Continuing Education

Access high-quality, clinically relevant education from Imedex and NACCME.

Advances in Anti-Cytokine Therapy: The Current and Potential Role of IL-12/23 and IL-23 Inhibitors in the Treatment of IBD
Leveraging JAK Inhibitors in Ulcerative Colitis: Strategies for the IBD Management Team
Optimizing IBD Management: New and Emerging Therapeutic Targets
Advances in Anti-Cytokine Therapy: The Current and Potential Role of IL-12/23 and IL-23 Inhibitors in the Treatment of IBD
Addressing Disease Progression in Psoriatic Arthritis: Optimizing Targeted Therapies
The Evolving Therapeutic Paradigm in IBD: Optimal Positioning of New and Emerging Agents
The Expanding Role of JAK Inhibitors Across IMIDs
The Current State of Psoriasis Treatment with Targeted Therapy
Ensuring Optimal IBD Care in the Era of COVID-19
Ensuring Optimal IBD Care in the Era of COVID-19
Back to Top